A Phase 1/2 Study of TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Clinical trial NCT04458389 · UNKNOWN

Trial details

NCT number: NCT04458389
Sponsor: Tayu Huaxia Biotech Medical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced /Metastatic Solid Tumors Relapsed or Refractory Lymphomas

Start date: 2020-12-07
Primary completion: 2024-06-30
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.